The 13th Annual New Therapeutics in Oncology covers topics such as:
- Personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options
- New, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of cancer patients
- Utilizing AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning
- Integrating appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes
- Anticipating the needs and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team
The 13th Annual New Therapeutics in Oncology brings together Specialties in:
- Internal Medicine
- Hematology
- Pain Management
- Oncology
- Surgery
- Radiation Oncology
The 13th Annual New Therapeutics in Oncology might be held in Los Angeles, United States in Nov 2024.
